Related Experiment Video
Updated: Aug 1, 2025

Author Spotlight: Unveiling the Polyfunctionality and Heterogeneity in Immune Responses
Published on: March 8, 2024
Meta-analysis informed machine learning: Supporting cytokine storm detection during CAR-T cell Therapy
Alex Bogatu1, Magdalena Wysocka2, Oskar Wysocki1
1Department of Computer Science, The University of Manchester, United Kingdom; Digital Experimental Cancer Medicine Team, Cancer Biomarker Centre, CRUK Manchester Institute, United Kingdom.
Machine learning can now identify cytokine release syndrome (CRS) by analyzing cytokine profiles. This method improves upon limited patient data by incorporating literature, aiding swift diagnosis of this cancer therapy side effect.
Area of Science:
- Oncology
- Immunology
- Computational Biology
Background:
- Cytokine release syndrome (CRS), or cytokine storm, is a significant adverse effect of chimeric antigen receptor (CAR) T-cell therapy.
- CRS onset is characterized by specific, yet variable, cytokine and chemokine profiles across patients.
- Accurate and timely diagnosis of CRS is crucial for managing cancer patients undergoing CAR T-cell therapy.
Purpose of the Study:
- To develop a novel, meta-review informed machine learning method for identifying CRS.
- To address the challenge of limited patient data in machine learning models for CRS detection.
- To enhance the accuracy and interpretability of CRS diagnosis using clinical data and literature.
Main Methods:
- Utilized machine learning algorithms to analyze similarities in patient cytokine profiles.
- Augmented limited patient cytokine concentration data with statistical knowledge extracted from domain literature.
- Pioneered a meta-review informed approach combining clinical study evidence with patient data.
Main Results:
- Achieved over 90% accuracy in identifying CRS.
- Demonstrated that the proposed method outperforms purely data-driven approaches.
- Showcased the interpretability of the model's results when applied to real-world CRS clinical data.
Conclusions:
- The developed machine learning method effectively identifies CRS onset using cytokine peak concentrations and literature data.
- Augmenting data with domain knowledge improves model performance and addresses data scarcity.
- This approach offers a valuable tool for clinicians to support swift and accurate CRS diagnosis in cancer patients.
More Related Videos
06:37Using Reference Reagents to Confirm Robustness of Cytokine Release Assays for the Prediction of Monoclonal Antibody Safety
Published on: September 15, 2023
12:36Single-cell Analysis of Immunophenotype and Cytokine Production in Peripheral Whole Blood via Mass Cytometry
Published on: June 26, 2018